Abiomed, a Johnson & Johnson unit, is removing Automated Impella Controllers after an FDA alert tied the devices to 37 serious injuries and three deaths. The company attributed the issue to purge cassette recognition problems, which can affect the controller’s management of the Impella catheter. The automated controller is positioned as the primary user interface for the Impella system, controlling catheter performance, monitoring alarms, and providing catheter positioning information. Abiomed’s recall-driven corrective action is expected to reduce risk while the company addresses recognition and related workflow failures. For hospitals and biotech-adjacent med-tech developers, the episode is a reminder that software-controlled device interfaces and supply-chain components can introduce new failure modes even when clinical outcomes depend on established mechanical support performance.